z-logo
open-access-imgOpen Access
COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
Author(s) -
Muhammad Farooq,
Muhammad Farooq,
Arfan ul Bari,
Tariq Malik
Publication year - 2021
Publication title -
pakistan armed forces medical journal
Language(s) - English
Resource type - Journals
eISSN - 2411-8842
pISSN - 0030-9648
DOI - 10.51253/pafmj.v71i1.3187
Subject(s) - meglumine antimoniate , medicine , chloroquine , meglumine , cutaneous leishmaniasis , gastroenterology , urine , group b , physical examination , leishmaniasis , dermatology , surgery , malaria , pathology , magnetic resonance imaging , radiology
Objective: To compare the efficacy of oral chloroquine with systemic meglumine antimoniate in treatment ofcutaneous leishmaniasis. Study Design: Open-label comparative prospective study. Place and Duration of Study: Study was conducted in the department of Dermatology, Combined MilitaryHospital Multan, from Jan to Oct 2018. Methodology: Fifty adult male patients completed the study. The inclusion criteria for the study were patientshaving untreated skin lesions less than 3 months old. Diagnosis was made on the basis of history and clinicalfeatures and was confirmed on histopathological examination. Patients were divided into 2 groups of 25 each,group A patients received meglumine antimoniate 810mg intramuscularly once a day whereas group B patientswere given oral chloroquine 250mg twice a day. Pre-treatment complete physical examination was done alongwith blood complete picture, urine routine examination, liver function tests, renal function tests and electrocadiogram. They were repeated after 2 weeks and at the end of treatment. The efficacy was measured by healing of lesions with a measuring tape. Results: Fifty patients completed the study. At the end of treatment, among group A patients, 4 (16%) showedno improvement, 21 (84%) improved; whereas in group B patients, 11 (44%) showed no improvement, 14 (56%)showed improvement. Percentage reduction in surface area of skin lesions was 77.6% in group A, whereas ingroup B, it was 42.7%. Conclusion: Meglumine antimoniate showed better efficacy than chloroquine but oral chloroquine was alsoeffective and can be used as an alternative therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here